![Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial | Journal of Nuclear Medicine Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/early/2024/01/10/jnumed.123.266211/F1.large.jpg)
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial | Journal of Nuclear Medicine
![Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019 - Liszkay - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019 - Liszkay - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7af08224-1ad7-4452-853e-7a2e84bb5cd8/jdv18960-fig-0001-m.jpg)
Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019 - Liszkay - 2023 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
![Diagnostics | Free Full-Text | Prognostic Value for Perioperative Serum Total Cholesterol Level on Postoperative Long-Term Prognosis of Pancreatic Cancer: A Retrospective Clinical Study Diagnostics | Free Full-Text | Prognostic Value for Perioperative Serum Total Cholesterol Level on Postoperative Long-Term Prognosis of Pancreatic Cancer: A Retrospective Clinical Study](https://pub.mdpi-res.com/diagnostics/diagnostics-13-01402/article_deploy/html/images/diagnostics-13-01402-g006.png?1682230952)
Diagnostics | Free Full-Text | Prognostic Value for Perioperative Serum Total Cholesterol Level on Postoperative Long-Term Prognosis of Pancreatic Cancer: A Retrospective Clinical Study
![Overall survival according to long-term responses (A). Comparison of... | Download Scientific Diagram Overall survival according to long-term responses (A). Comparison of... | Download Scientific Diagram](https://www.researchgate.net/publication/357887379/figure/fig2/AS:1113284711317506@1642439167587/Overall-survival-according-to-long-term-responses-A-Comparison-of-response-rates-B.png)
Overall survival according to long-term responses (A). Comparison of... | Download Scientific Diagram
![Survival outcomes. (A) Long term overall survival of 291 patients with... | Download Scientific Diagram Survival outcomes. (A) Long term overall survival of 291 patients with... | Download Scientific Diagram](https://www.researchgate.net/publication/351648380/figure/fig2/AS:11431281173619438@1688995655199/Survival-outcomes-A-Long-term-overall-survival-of-291-patients-with-POEMS-syndrome.png)
Survival outcomes. (A) Long term overall survival of 291 patients with... | Download Scientific Diagram
![How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2015.65.4012/asset/images/large/jco654012f4.jpeg)
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology
![JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme](https://dm5migu4zj3pb.cloudfront.net/manuscripts/138000/138649/medium/JCI138649.f7.jpg)
JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
![Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience - ScienceDirect Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118625017-gr1.jpg)
Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience - ScienceDirect
![Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis | Investigational New Drugs Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis | Investigational New Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10637-021-01183-6/MediaObjects/10637_2021_1183_Fig2_HTML.png)
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis | Investigational New Drugs
![Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment - Zhaojing Che, Nathan Green, Gianluca Baio, 2023 Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment - Zhaojing Che, Nathan Green, Gianluca Baio, 2023](https://journals.sagepub.com/cms/10.1177/0272989X221134545/asset/images/large/10.1177_0272989x221134545-fig1.jpeg)
Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment - Zhaojing Che, Nathan Green, Gianluca Baio, 2023
![Long-Term Overall Survival (OS) with Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Updated Results from the Phase 3 QUAZAR AML-001 Trial - Long-Term Overall Survival (OS) with Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Updated Results from the Phase 3 QUAZAR AML-001 Trial -](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121028597-gr1.jpg)
Long-Term Overall Survival (OS) with Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Updated Results from the Phase 3 QUAZAR AML-001 Trial -
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
![Long-term survival. a-b Overall survival (a) and relapse-free survival... | Download Scientific Diagram Long-term survival. a-b Overall survival (a) and relapse-free survival... | Download Scientific Diagram](https://www.researchgate.net/publication/344216933/figure/fig3/AS:937333578797059@1600489148193/Long-term-survival-a-b-Overall-survival-a-and-relapse-free-survival-b-of-the-20-R-R.png)
Long-term survival. a-b Overall survival (a) and relapse-free survival... | Download Scientific Diagram
![Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer - The Lancet Regional Health - Southeast Asia Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer - The Lancet Regional Health - Southeast Asia](https://www.thelancet.com/cms/attachment/c1c971a6-2e96-4acc-90b9-9852ce4e355d/gr1.jpg)
Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer - The Lancet Regional Health - Southeast Asia
![Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism - Biology of Blood and Marrow Transplantation Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2005054060/2021542082/gr1.jpg)
Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism - Biology of Blood and Marrow Transplantation
![Long term survival and disease burden from out-of-hospital cardiac arrest in Singapore: a population-based cohort study - The Lancet Regional Health – Western Pacific Long term survival and disease burden from out-of-hospital cardiac arrest in Singapore: a population-based cohort study - The Lancet Regional Health – Western Pacific](https://www.thelancet.com/cms/attachment/9ad042df-46bc-4c89-9cf6-1f5b893b1c29/gr1.jpg)
Long term survival and disease burden from out-of-hospital cardiac arrest in Singapore: a population-based cohort study - The Lancet Regional Health – Western Pacific
![Cancers | Free Full-Text | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials Cancers | Free Full-Text | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials](https://pub.mdpi-res.com/cancers/cancers-15-02050/article_deploy/html/images/cancers-15-02050-g003.png?1681106632)
Cancers | Free Full-Text | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials
![Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13045-019-0835-1/MediaObjects/13045_2019_835_Fig4_HTML.png)
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text
![Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group - Mettmann - 2023 - Cancer Medicine - Wiley Online Library Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group - Mettmann - 2023 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ca0dd9bc-185e-47f3-9756-35dca7b108a8/cam46409-toc-0001-m.jpg?trick=1703629512736)
Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group - Mettmann - 2023 - Cancer Medicine - Wiley Online Library
![How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2015.65.4012/asset/images/large/jco654012f2.jpeg)
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors | Journal of Clinical Oncology
![Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood Estimating Long-Term Survival for Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy: A Comparison of Standard and Mixture Cure Models - Biology of Blood](https://www.astctjournal.org/cms/attachment/2119122619/2089439753/ybbmt54915-fig-0007.jpg)